Departments of Surgery, East Tennessee State University, Johnson City, TN, USA; Drug Discovery and Synthesis Core, East Tennessee State University, Johnson City, TN, USA; Center for Inflammation, Infectious Disease and Immunity, Quillen College of Medicine, East Tennessee State University, Johnson City, TN, USA.
Departments of Surgery, East Tennessee State University, Johnson City, TN, USA; Drug Discovery and Synthesis Core, East Tennessee State University, Johnson City, TN, USA; Center for Inflammation, Infectious Disease and Immunity, Quillen College of Medicine, East Tennessee State University, Johnson City, TN, USA.
Carbohydr Res. 2024 Mar;537:109059. doi: 10.1016/j.carres.2024.109059. Epub 2024 Feb 20.
Candida auris is an emerging fungal pathogen that has become a world-wide public health threat. While there have been numerous studies into the nature, composition and structure of the cell wall of Candida albicans and other Candida species, much less is known about the C. auris cell wall. We have shown that C. auris cell wall mannan contains a unique phosphomannan structure which distinguishes C. auris mannan from the mannans found in other fungal species. Specifically, C. auris exhibits two unique acid-labile mannose α-1-phosphate (Manα1PO) sidechains that are absent in other fungal mannans and fungal pathogens. This unique mannan structural feature presents an opportunity for the development of vaccines, therapeutics, diagnostic tools and/or research reagents that target C. auris. Herein, we describe the successful synthesis and structural characterization of a Manα1PO-containing disaccharide moiety that mimics the phosphomannan found in C. auris. Additionally, we present evidence that the synthetic Manα1PO glycomimetic is specifically recognized and bound by cell surface pattern recognition receptors, i.e. rhDectin-2, rhMannose receptor and rhMincle, that are known to play important roles in the innate immune response to C. auris as well as other fungal pathogens. The synthesis of the Manα1PO glycomimetic may represent an important starting point in the development of vaccines, therapeutics, diagnostics and research reagents which target a number of C. auris clinical strains. In addition, these data provide new insights and understanding into the structural biology of this unique fungal pathogen.
耳念珠菌是一种新兴的真菌病原体,已成为全球公共卫生威胁。虽然已经有许多研究关注白色念珠菌和其他念珠菌属物种的细胞壁的性质、组成和结构,但对于耳念珠菌的细胞壁知之甚少。我们已经表明,耳念珠菌细胞壁甘露聚糖含有独特的磷酸甘露聚糖结构,将耳念珠菌甘露聚糖与其他真菌物种中的甘露聚糖区分开来。具体来说,耳念珠菌表现出两种独特的酸不稳定甘露糖α-1-磷酸(Manα1PO)侧链,这些侧链在其他真菌甘露聚糖和真菌病原体中不存在。这种独特的甘露聚糖结构特征为开发针对耳念珠菌的疫苗、疗法、诊断工具和/或研究试剂提供了机会。在此,我们描述了成功合成并结构表征了一种含有 Manα1PO 的二糖部分,该部分模拟了在耳念珠菌中发现的磷酸甘露聚糖。此外,我们还提供了证据表明,合成的 Manα1PO 糖模拟物被细胞表面模式识别受体(即 rhDectin-2、rhMannose 受体和 rhMincle)特异性识别和结合,这些受体已知在针对耳念珠菌以及其他真菌病原体的先天免疫反应中发挥重要作用。Manα1PO 糖模拟物的合成可能代表了针对许多耳念珠菌临床菌株的疫苗、疗法、诊断和研究试剂的开发的重要起点。此外,这些数据为该独特真菌病原体的结构生物学提供了新的见解和理解。